⑤管理方針（ASCCPなど） ・単なる再細胞診のみによる観察は原則不可 ・コルポスコピー＋子宮頸管内評価を推奨 ・35歳以上・不正出血あり(検診のコンテクストではないが）・子宮内膜がんリスク因子がある場合は子宮内膜評価の追加が推奨される→

Cervical cancer is one of the most preventable cancers, and screening matters. Updated guidelines supported by SGO and ASCCP expand options, including Pap testing, HPV testing, co-testing and self-collected HPV testing. Talk with your provider. #AskHer #FWC

Cervical cancer is preventable, and screening is key. SGO, with ASCCP, endorses updated ACS & ACOG guidelines expanding options like Pap testing, co-testing, and self-collected HPV testing for everyone with a cervix. Talk with patients. #CancerPrevention #HPV #GynOnc

Professionally, I have seen *NO DISCUSSION* of the implications and risks of HPV related disease and repeat SARS2 infections from ACOG, ASCCP, or NPWH. And this continues to be a major concern amid our very unstable political environment here in the US.

Hastada 46 yaşta, HPV 31-52-59 olmak üzere çoklu yüksek riskli HPV pozitifliği mevcuttur. Böyle durumlarda kolposkopiyi 16/18 dışında da risk-temelli yönetim yaklaşımı nedeniyle öneririz. Risk sadece smear ile belirlenmez; şu faktörler de önemlidir. Yaş, HPV tipi, Tekli / çoklu HPV varlığı, Persistans olasılığı… Smear’in normal olması riski sıfırlamaz. Çünkü smear bir “Tarama” testidir, Duyarlılığı sınırlıdır. Erken CIN lezyonları smear’de atlanabilir (özellikle transformation zone atlanabilir, yetersiz gelebilir) Kısaca ; ASCCP 2019 risk-temelli yönetim yaklaşımı ve Avrupa servikal tarama kılavuzları doğrultusunda, yaş ve çoklu HR-HPV varlığına bağlı artmış kümülatif risk nedeniyle kolposkopik değerlendirme önerilmiştir. (Not: Kolposkopi devlet hastanelerinde SGK kapsamında ücretsiz yapılan bir işlemdir)

Такие рекомендации по всему миру: ВОЗ, ASCCP, ACOG и другие Чаще, не значит лучше, скажем так Рак развивается очень медленно и эти временные сроки адекватные для скрининговых методов у девушек, у кого раньше не было проблем с шейкой

LSILはCIN1相当で高リスクHPVでも1年で7割が消失し、CIN3へ進むのは1〜2％未満だと思います。がん化は長期持続が前提です。現時点で致死的リスクはゼロに等しいかと思います。ASCCP指針通りまずはコルポ診＋必要なら生検で確定させてください。詳しくは担当の医師にご確認を。

Yes, in the US, physicians follow established guidelines for pain management during cervical biopsies (typically performed as part of a colposcopy-directed procedure), primarily outlined by the American College of Obstetricians and Gynecologists (ACOG) and the American Society for Colposcopy and Cervical Pathology (ASCCP). These emphasize shared decision-making, patient education to manage expectations, and evidence-based options, as colposcopy with biopsy is an outpatient procedure where pain is often described as cramping similar to menstrual discomfort, with visual analog scale (VAS) scores typically ranging from 4–6 out of 10 during tissue sampling. The 2025 ACOG Clinical Consensus on Pain Management for In-Office Uterine and Cervical Procedures and ASCCP's 2023 Colposcopy Standards provide the core framework, prioritizing non-invasive methods while offering pharmacologic relief based on individual needs.

Check out the new editor's choice video series Part 1! This is reviewing the #cervicalcancer consensus article from @SGO_org, @acog, @ASCCP, ASTRO, and @AmericanBrachy

This consensus statement highlights how #CervicalCancer outcomes are shaped by #SocialDeterminantsOfHealth. Discussions include: the urgent need to expand #healthcareaccess, increase inclusive clinical trial enrollment, and address rurality & poverty in #cancerprevention. @SGO_org @acog @ASCCP #ASTRO #ABS #GynOnc #WHO #CancerAwareness #worldhealthorganization Readmore:sciencedirect.com/science/ar…

D because dumbasses forgot the HPV cotest swab so that the ASCCP pap smear calculator actually works

The BD Onclarity™ HPV Assay is part of the @ASCCP guidelines which have just been made available on its mobile app, downloaded for use by 150,000 clinicians in the U.S. to help inform their decision-making with an aim toward improving patient care. asccp.org/mobile-app

A retrospective study by @CherylRClarkMD et al revealed 1/3 of patients with an abnormal cervical cancer screening test lack historical data to optimally follow 2019 ASCCP risk-based management guidelines for cervical cancer screening buff.ly/VlZLHVY #cervicalcancer

如果病情真如視頻中女子所說是「上皮內瘤變三級」（CIN III）那麼，這是比較嚴重的子宮頸感染HPV的病理表現，幾乎等同於「原位癌」（Carcinoma in situ）！絕對不是大多數育齡婦女都有的情況。按照美國ASCCP 2019指南首選子宮頸環切或錐切術。如果是浸潤癌，多數需要宮頸/子宮聯合切除。 BUT：

Prevenir mejor el cáncer de cérvix: el papel del genotipado del #VPH para adaptar los seguimientos a las necesidades reales. pmc.ncbi.nlm.nih.gov/article… @ASCCP @aepccolposcopia @ContraCancerEs @ContraCancerIB @ibsalut

ASCCP even recommended *against* any kind of anesthesia for endocervical curettage These recommendations relied on average treatment effects despite the fact that the primary issue is the small number of women who experience severe pain

Join this CAP Foundation webinar with Dr. Mark Stoler to explore HPV primary screening, extended genotyping, self-collection, and their impact on patient care. Link to register: brnw.ch/21wSCpa Help Spread the word: @UVA @ASCCP @PamelaToliman @JuliaBCancerSci

Join this CAP Foundation webinar with Dr. Mark Stoler to explore HPV primary screening, extended genotyping, self-collection, and their impact on patient care. Link to register: brnw.ch/21wSywA Help Spread the word: @UVA @ASCCP @PamelaToliman @JuliaBCancerSci

Check out our Stowell-Orbison Award Poster by Sarah Kisha, MD 📅 Monday March 24 ⏰9:30 AM–12:00 PM 📌 Board #30 | Cytopathology Title: HPV Cotesting of Unsatisfactory ThinPrep Pap Tests: A Study on Assurance of Negative HPV Results and Compliance with ASCCP Guidelines @cytopathology @JASCJOURNAL @CancerCytopath @CytopathologyJ @CytopathologyJ #HFHPath #Pathology #learnleadbelong #BostonBound #USCAP2025 #USCAP25 #IAMUSCAP #HFHPathres #PathTwitter #PathX #pathology #matchtopath #path2path @PathPod #conference #boston

BD Onclarity™ HPV Assay is now part of ASCCP guidelines, enhancing precision in HPV screening and cervical cancer prevention. Dr. Jeff Andrews discusses the benefits of extended genotyping. Read the article in CLP. bit.ly/40Rb9sI #CervicalCancer #HPVTesting #CCAM